ClinicalTrials.govpublic full text
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
metabolic syndrome, obesity & overweight, hiv (human immunodeficiency virus)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 181696
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.